David Iglesias, MD : Research

Cancer Specialist (Oncologist), Gynecologic Oncologist (Gynecological Cancer Specialist)

4.9

52 ratings 6 reviews

Additional languages:: Spanish

(352) 265-8200 MyUFHealth

Research at a glance

Top areas of exploration

Endometrial Neoplasms , 9 publications
Metformin , 5 publications
Uterine Neoplasms , 4 publications
Carcinoma, Endometrioid , 4 publications

Research activity

24 publications

1,211 citations

Why is this important?

Active clinical trials

Phase 3 Study of sac-TMT Plus Pembrolizumab as 1L Maintenance in pMMR Endometrial Cancer

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advanced or recurrent. EC is a type of cancer that starts in the tissues inside the uterus (womb) pMMR indicates that…

Investigator: David Iglesias
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: Female

Comparing Two Surgical Procedures in Individuals with Ovarian Cancer+BRCA1 Mutations(SOROCk)

This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the…

Investigator: David Iglesias
Status: Accepting Candidates
Ages: 35 Years - 50 Years
Sexes: Female

My publications

24 publications

2025

Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study.

European journal of cancer (Oxford, England : 1990)

PubMed • Publisher's site

2023

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

The New England journal of medicine

PubMed • Publisher's site

2023

Dysgerminoma Masquerading as Gestational Trophoblastic Neoplasia.

Case reports in obstetrics and gynecology

PubMed • Publisher's site

2022

Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.

Gynecologic oncology

PubMed • Publisher's site

2022

Endometrial Cancer Characteristics and Risk of Recurrence.

American journal of clinical pathology

PubMed • Publisher's site

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study.

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

Dysgerminoma Masquerading as Gestational Trophoblastic Neoplasia.

Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.

Endometrial Cancer Characteristics and Risk of Recurrence.